Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex
Open Access
- 1 October 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 46 (4) , 571-576
- https://doi.org/10.1093/jac/46.4.571
Abstract
The in vitro activity of rifapentine for 44 clinical isolates of Mycobacterium tuberculosis complex was compared with that of rifampicin using the Bactec radiometric method and the absolute concentration method for susceptibility testing. Twenty-nine M. tuberculosis, 11 Mycobacterium bovis and four Mycobacterium africanum strains were studied. Control tests showed that rifapentine was stable for 14 days in 7H9 broth and for 3 weeks in 7H10 agar medium. The 44 M. tuberculosis complex strains were more susceptible to rifapentine than to rifampicin, irrespective of the testing method. In the radiometric system, the MIC50 and MIC90 of rifapentine for M. tuberculosis complex strains were one or two two-fold dilutions lower than those of rifampicin (0.06–0.125 mg/L versus 0.25 mg/L, respectively). By the absolute concentration method, the MIC50 and MIC90 of rifapentine for M. tuberculosis complex strains were two two-fold dilutions lower than those of rifampicin (0.125–0.25 mg/L versus 0.5–1 mg/L, respectively). The MIC90 of rifapentine for the 44 M. tuberculosis complex strains was always 0.25 mg/L, irrespective of the method used, but the radiometric method was more reliable and more reproducible than the agar 7H10 method.Keywords
This publication has 21 references indexed in Scilit:
- Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalisJournal of Antimicrobial Chemotherapy, 1999
- Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal MacrophagesAmerican Review of Respiratory Disease, 1992
- Bactericidal ActivityIn Vitroof Various Rifamycins againstMycobacterium aviumandMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1990
- In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisTubercle, 1987
- In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisTubercle, 1987
- Comparative uptake of rifampicin and rifapentine (DL473) by human neutrophilsJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics of rifapentine, a new long lasting rifamycin, in the rat, the mouse and the rabbit.The Journal of Antibiotics, 1984
- Comparison of the sensitivity of mycobacteria to the cyclopentyl rifamycin DL473 and rifampicinJournal of Antimicrobial Chemotherapy, 1982
- Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.The Journal of Antibiotics, 1981
- Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]Published by Wiley ,1978